Thursday, 29 September 2016
Draft Agenda- Subject to Change | ||||
08:00 | Registration | |||
09:00 | Inauguration | |||
09:20 |
| |||
09:40 |
| |||
Session I: Emerging Trends in Antibody Drug Conjugates | ||||
10:10 | Coffee Break and Networking in the Exhibition Area | |||
10:40 | Antibody Drug Conjugates- Current Status & Future Prospects | |||
11:10 |
| |||
Session II: ADC for Cancer Treatment | ||||
11:55 | ADC - A Magic Bullet to Cancer Therapy | |||
12:40 |
| |||
13:40 | Lunch Break and Networking in the Exhibition Area | |||
Session III: Advances in Antibody and ADC-I | ||||
14:40 | Cell Line Engineering Approaches towards Quantity and Quality Improvement of Recombinant mAb | |||
15:25 | Antibody Drug Conjugates beyond Cancer Therapeutics | |||
16:10 | Coffee Break and Networking in the Exhibition Area | |||
Session IV: Advances in Antibody and ADC-II | ||||
16:40 | Monoclonal Antibody and Drug combination Therapy for an Effective Treatment of Type I Diabetes | |||
17:10 | Title to be Finalized | |||
17:55 | End of Day 1 of Conference | |||
Friday, 30 September 2016
09:30 |
| |||
10:15 | Coffee Break and Networking in the Exhibition Area | |||
Session V: Advances in Development & Analysis of ADCs | ||||
10:45 | Plenary Talk: Antibody based Radiopharmaceuticals for Diagnosis and Therapy | |||
11:45 | Best Practices in Developing Bioanalytical Assays for Assessment of Antibody-Drug Conjugates | |||
12:30 | ADCs : Analytical Approaches | |||
13:00 | Poster Viewing | |||
13:15 | Lunch Break and Networking in the Exhibition Area | |||
Session VI: Novel Approaches in ADC | ||||
14:15 |
| |||
15:15 | Development of Robust, Scalable Site-Specific Conjugation for Monoclonal and Bispecific mAbs: A DOE Approach | |||
16:00 | Coffee Break and Networking in the Exhibition Area | |||
16:30 | Panel Discussion: Drug Discovery and ADC- An Industry Perspective | |||
17:20 | End of Conference | |||
